Taina Rantanen

Taina Rantanen


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
Fulvio LauretaniFulvio Lauretani
Fulvio Lauretani
CRCosimo Roberto Russo
Cosimo Roberto Russo
SBStefania Bandinelli
Stefania Bandinelli
BBBenedetta Bartali
Benedetta Bartali
CCChiara Cavazzini
Chiara Cavazzini
LFLuigi Ferrucci
Luigi Ferrucci
Sarcopenia, the reduction of muscle mass and strength that occurs with aging, is widely considered one of the major causes of disability in older persons. Surprisingly, criteria that may help a clinician to identify persons with impaired muscle function are still lacking. Using data from a large representative sample of the general population, we examined how muscle function and calf muscle area change with aging and affect mobility in men and women free of neurological conditions. We tested several putative indicators of sarcopenia, including knee extension isometric torque, handgrip, lower extremity muscle power, and calf muscle area. For each indicator, sarcopenia was considered to be present when the measure was >2 SDs below the mean. For all four measures, the prevalence of sarcopenia increased with age, both in men and women. The age-associated gradient in prevalence was maximum for muscle power and minimum for calf-muscle area. However, lower extremity muscle power was no better than knee-extension torque or handgrip in the early identification of poor mobility, defined either as walking speed <0.8 m/s or inability to walk at least 1 km without difficulty and without developing symptoms. Optimal cutoff values that can be used in the clinical practice to identify older persons with poor mobility were developed. The findings of the study lay the basis for a cost-effective, clinical marker of sarcopenia based on a measure of isometric handgrip strength. Our findings should be verified in a longitudinal study.

10 February 1999 in JAMA
Verified
Journal Article
Open access
PDF file
TRTaina Rantanen
Taina Rantanen
JGJack M. Guralnik
Jack M. Guralnik
DFDan Foley
Dan Foley
KMKamal Masaki
Kamal Masaki
SLSuzanne Leveille
Suzanne Leveille
LWLon White
Lon White
In old age, decreased muscle strength predisposes people to functional limitations and disability.1-3 Cross-sectionally, muscle strength is significantly, but not linearly, associated with functional limitations such as walking speed.4-7 A minimum level of strength is needed to perform tasks. Conversely, when strength is well above the minimum required level, a reserve capacity exists.4,5,7 Reserve capacity serves as a safety margin that helps prevent functional limitations from developing, eg, following inactivity and deconditioning associated with surgery or an acute illness.

1 November 2008 in Current Opinion in Clinical Nutrition and Metabolic Care
Verified
Journal Article
Closed access
SSSari Stenholm
Sari Stenholm
THTamara B Harris
Tamara B Harris
TRTaina Rantanen
Taina Rantanen
MVMarjolein Visser
Marjolein Visser
SKStephen B Kritchevsky
Stephen B Kritchevsky
LFLuigi Ferrucci
Luigi Ferrucci
Purpose of review Older obese persons with decreased muscle mass or strength are at special risk for adverse outcomes. We discuss potential pathways to muscle impairment in obese individuals and the consequences that joint obesity and muscle impairment may have on health and disability. Tantamount to this discussion is whether low muscle mass or, rather, muscle weakness should be used for the definition. Recent findings Excess energy intake, physical inactivity, low-grade inflammation, insulin resistance and changes in hormonal milieu may lead to the development of so-called ‘sarcopenic obesity’. It was originally believed that the culprit of age-related muscle weakness was a reduction in muscle mass, but it is now clear that changes in muscle composition and quality are predominant. We propose that the risk of adverse outcomes, such as functional limitation and mortality, is better estimated by considering jointly obesity and muscle strength rather than obesity and muscle mass and the term ‘sarcopenic obesity’ should be revisited. Summary Recognition of obese patients who have associated muscle problems is an essential goal for clinicians. Further research is needed to identify new target for prevention and cure of this important geriatric syndrome.

13 December 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
WCWellcome Trust Case Control Consortium
Wellcome Trust Case Control Consortium
EREmmanouela Repapi
Emmanouela Repapi
TTThe NSHD Respiratory Study Team
The NSHD Respiratory Study Team
ISIan Sayers
Ian Sayers
LWLouise V Wain
Louise V Wain
MTMartin D Tobin
Martin D Tobin
Martin Tobin and colleagues present genome-wide association studies for pulmonary function as part of the SpiroMeta consortium. Pulmonary function measures are heritable traits that predict morbidity and mortality and define chronic obstructive pulmonary disease (COPD). We tested genome-wide association with forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) in the SpiroMeta consortium (n = 20,288 individuals of European ancestry). We conducted a meta-analysis of top signals with data from direct genotyping (n ≤ 32,184 additional individuals) and in silico summary association data from the CHARGE Consortium (n = 21,209) and the Health 2000 survey (n ≤ 883). We confirmed the reported locus at 4q31 and identified associations with FEV1 or FEV1/FVC and common variants at five additional loci: 2q35 in TNS1 (P = 1.11 × 10−12), 4q24 in GSTCD (2.18 × 10−23), 5q33 in HTR4 (P = 4.29 × 10−9), 6p21 in AGER (P = 3.07 × 10−15) and 15q23 in THSD4 (P = 7.24 × 10−15). mRNA analyses showed expression of TNS1, GSTCD, AGER, HTR4 and THSD4 in human lung tissue. These associations offer mechanistic insight into pulmonary function regulation and indicate potential targets for interventions to alleviate respiratory disease.

29 April 2003 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
TRTaina Rantanen
Taina Rantanen
SVStefano Volpato
Stefano Volpato
LFLuigi Ferrucci
Luigi Ferrucci
EHEino Heikkinen
Eino Heikkinen
LFLinda P. Fried
Linda P. Fried
JGJack M. Guralnik
Jack M. Guralnik

1 May 2000 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
MHMirja Hirvensalo
Mirja Hirvensalo
TRTaina Rantanen
Taina Rantanen
EHEino Heikkinen
Eino Heikkinen